During the current abortion, the vast majority (94.6%) chose sublingual Misoprostol; while 94.4% among the pregnancies ≤ 7 weeks selected to use at home; the corresponding rate among pregnancies > 7 weeks to ≤ 8 weeks was 26.1%.